You are here

  • Home
  • Archive
  • Volume 13, Issue 1
  • Prebiotic supplementation of formula milk increases stool counts of bifidobacteria and lactobacilli compared with unsupplemented formula milk in full-term neonates

Article Text

Article menu
Download PDFPDF
Therapeutics
Systematic review
Prebiotic supplementation of formula milk increases stool counts of bifidobacteria and lactobacilli compared with unsupplemented formula milk in full-term neonates
  1. Yvan Vandenplas
  1. Yvan Vandenplas
    UZ Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium; yvan.vandenplas{at}uzbrussel.be

https://doi.org/10.1136/ebn1010

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Rao S, Srinivasjois R, Patole S. Prebiotic supplementation in full-term neonates: a systematic review of randomized controlled trials. Arch Pediatr Adolesc Med 2009;163:755–64.OpenUrlCrossRefPubMedWeb of Science

    It has been known for many years that oligosaccharides are a substantial component of human milk. Neither other animal species’ milk nor soy milk contains oligosaccharides. Human milk contains more than 130 oligosaccharides that differ substantially (as do all components) over lactation and from woman to woman. As Rao and colleagues state in their introduction, early colonisation is a critical determinant of the permanent gut flora. And oligosaccharides are detrimental to the development of gut flora.

    The first choice for infant feeding is exclusive breast feeding. The effect of second-choice infant feeding (infant formula) …

    View Full Text

    Footnotes

    • Competing interests During the past five years, YVDP has received funds for research and reimbursement for costs related to presentations at international meetings from Abbott, Danone, Mead Johnson, Nestlé and United Pharmaceuticals